Replies to post #28444 on Lexaria Bioscience Corp (LEXX)

[Shawking]

Gilead says it has no plans to turn remdesivir into a pill. “Based on our understanding of remdesivir from preclinical studies, intravenous administration allows for the most stability and appropriate levels of the drug in the blood system,” a company spokesperson tells C&EN.
https://cen.acs.org/biological-chemistry/infectious-disease/initial-remdesivir-data-tell-us/98/i13

Perhaps DehydraTECH can give them the stability and appropriate level of the drug in the bloodstream with an oral product for the masses.